Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami

Journal of Addictive Diseases

Volumn 27, Issue 2, 2008, Pages 37-48

  Baum, Marianna K ^a   Jayaweera, Dushyantha T ^b   Duan, Rui ^a   Sales, Sabrina ^a   Lai, Shenghan ^c   Rafie, Carlin ^a   Regev, Arie ^b   Page, J Bryan ^b   Berkman, Ronald ^a   Campa, Adriana ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Depression; HCV; Healthcare utilization; HIV; Quality of life

Indexed keywords

ILLICIT DRUG; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG ABUSE; DRUG USE; ETHNICITY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PHYSICAL EXAMINATION; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SYMPTOMATOLOGY; UNITED STATES; VIRUS LOAD; CHRONIC DISEASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYMOLOGY; IMMUNOLOGY; LIVER CIRRHOSIS; MAJOR DEPRESSION; MIDDLE AGED; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; RESIDENTIAL CARE; SUBSTANCE ABUSE; UTILIZATION REVIEW;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIGENS, CD4; ANTIVIRAL AGENTS; CATCHMENT AREA (HEALTH); CHRONIC DISEASE; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FLORIDA; HEALTH SERVICES; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 47949098487     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v27n02_05     Document Type: Article

References (44)

1. http://www.cdc.gov/hiv/pubs/facts/HIV-HCV-Coinfection.htm
2. http://www.thebodypro.com/sfaf/winter03/ coinfection.html#twin
3. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Internal Med. 2003;138: 197-207.
4. Shire NJ, Sherman KE. Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future. Clin Infect Dis 2005; 41(Suppl 1):S63-8.
5. Gebo KA, Diener-West M, Moore RD. Hospitalization rates differ by hepatitis C satus in an urban HIV cohort. J Acquir Immune Defic Syndr. 2003;34(2): 165-73.
6. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166(15):1632-41.
7. Kanwal F, Gralnek IM, Hays RD, Dulai GS, Spiegel BM, Bozzette S, Asch S. Impact of chronic viral hepatitis on health-related quality of life in HIV: results from a nationally representative sample. Am J Gastroenterol. 2005;100(9):1984-94.
8. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002 Mar 15;34(6):831-7.
9. Bartlett JG, Gallant JE. 2004 Medical Management of HIV Infection. Johns Hopkins Medicine Health Publishing Business Group, Baltimore MD, 2004: pp. 376-379.
10. Restrepo A, Johnson TC, Widjaja D, Yarmus L, Meyer K, Clain DJ, Bodenheimer HC Jr, Min AD. The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre. J Viral Hepat. 2005;12(1):86-90.
11. Fleming CA, Christiansen D, Nunes D, Heeren T, Thornton D, Horsburgh CR Jr, Koziel MJ, Graham C, Craven DE. Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection. Clin Infect Dis. 2004;38(4):572-8.
12. Conference Report Highlights of the 2nd International Workshop on HIV and Hepatitis Coinfection January 12-14, 2006; Amsterdam, The Netherlands.
13. Bräu N. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy. J Antimicrob Chemother. 2005;56(6):991-5.
14. Khalsa JH, Kresina T, Sherman K, Vocci F. Medical management of HIV-hepatitis C virus coinfection in injection drug users. Clin Infect Dis. 2005;41 Suppl 1:S1-6.
15. McGovern B, Fiore J, Wurcel A, Taglienti P, Bradley M, Galvin S, Libone G, Ramsey J, Molinaro-Gudas V, Drewniak S, Amick C, Andalkar A, Scheft H, Bica I. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients. Clin Infect Dis. 2005;41 Suppl 1:S56-62.
16. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology. 2005;41(4):790-800.
17. Braitstein P, Montessori V, Chan K, Montaner JS, Schechter MT, O'Shaughnessy MV, Hogg RS. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort. AIDS Care. 2005;17(4):505-15.
18. Hays RD, Cunningham WE, Sherbourne CD, Wilson IB, Wu AW, Cleary PD, McCaffrey F, Fleishman JA, Crystal S, Collins R, Eggan F, Shapiro MF, Bozzette SA. Health related quality of life in patient with human immune deficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med 2000;108:714-22.
19. Shor-Posner G, Lecusay R, Miguez-Burbano MJ, Quesada J, Rodriguez A, Ruiz P, O'Mellan S, Campa A, Rincon H, Wilkie F, Page JB, Baum MK. Quality of life measures in the Miami HIV-1 infected drug abusers cohort: relationship to gender and disease status. J Subst Abuse. 2000;11(4):395-404.
20. Lorenz KA, Shapiro MF, Asch SM, et al. Association of symptoms and health related quality of life: finding from a national study of persons with HIV. Ann Intern Med 2001;134:854-60.
21. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001;96: 2737-44.
22. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27:209-2.
23. Ware JE Jr, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999;30:550-5.
24. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999; 29:264-70.
25. Bernstein D, Kleinman L, Barher CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002; 35:704-8.
26. Kramer L, Hofer H, Bauer E, Funk G, Formann E, Steindl-Munda P, Ferenci P. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. AIDS. 2005;19 Suppl 3:S85-92.
27. Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, Wrba F, Madl C, Gangl A, Ferenci P. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol. 2002;37(3):349-54.
28. Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, Gasbarrini G. HCV infection and extra-hepatic manifestations. Hepatogastroenterology. 2003; 50(52):1149-54.
29. McCoy CB, Metsch LR, Comerford M, Zhao W, Coltes AJ, Messiah SE. Trends of HIV risk behaviors in a cohort of injecting drug users and their sex partners in Miami, Florida, 1988-1998. AIDS Behav. 2005;9(2): 187-99.
30. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis. 1981; 34(12):585-97.
31. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M; APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317-25.
32. Carretero MD, Burgess AP, Soler P, Soler M, Catalan J. Reliability and validity of an HIV-specific health-related quality-of-life measure for use with injecting drug users. AIDS. 1996;10(14):1699-705.
33. Mendes-Correa MC, Barone AA, Gianini RJ. Risk factors associated with hepatitis C among patients co-infected with human immunodeficiency virus: a case-control study. Am J Trop Med Hyg. 2005;72(6): 762-7.
34. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol. 1994;87(3):555-61.
35. Costa LB, Ferraz ML, Perez RM, Ferreira AS, Matos CA, Lanzoni VP, Silva AE. Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection. Braz J Infect Dis. 2002;6(5):219-24.
36. Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, Poynard T. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol. 2006;44(1 Suppl):S19-24.
37. Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36:S47-S56.
38. Braitstein P, Li K, Kerr T, Montaner JS, Hogg RS, Wood E. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone. AIDS Care. 2006;18(7):690-3.
39. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35(2): 433-9.
40. Obhrai J, Hall Y, Anand BS. Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection. J Clin Gastroenterol. 2001; 32(5):413-7.
41. Robbins JL, Phillips KD, Dudgeon WD, Hand GA. Physiological and psychological correlates of sleep in HIV infection. Clin Nurs Res. 2004;13(1):33-52.
42. Sullivan PS, Dworkin MS; Adult and Adolescent Spectrum of HIV Disease Investigators. Prevalence and correlates of fatigue among persons with HIV infection. J Pain Symptom Manage. 2003;25(4):329-33.
43. Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res. 2000;49(5):311-7.
44. Mohsen AH, Murad S, Easterbrook PJ. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. HIV Med. 2005;6(3): 206-15.